| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/06/2023 | scPharmaceuticals Inc. | SCPH | Grant | Stock Option (Right to Buy) | 17.3k | $11.71 | $202.6k | | 06/06/2023 |
| 06/09/2020 | scPharmaceuticals Inc. | SCPH | Grant | Stock Option (Right to Buy) | 6.1k | $7.96 | $48.7k | | 06/09/2020 |
| 03/16/2020 | Enliven Therapeutics, Inc. | IMRA | Grant | Stock Option (right to buy) | 15.5k | $16.00 | $247.3k | | 03/16/2020 |
| 03/16/2020 | Enliven Therapeutics, Inc. | IMRA | Conversion | Series B Preferred Stock | 1.9M | $0.00 | $0 | By Lundbeckfond Invest A/S | 03/16/2020 |
| 03/16/2020 | Enliven Therapeutics, Inc. | IMRA | Conversion | Series A Preferred Stock | 5.5M | $0.00 | $0 | By Lundbeckfond Invest A/S | 03/16/2020 |
| 03/16/2020 | Enliven Therapeutics, Inc. | IMRA | Conversion | Series Seed Preferred Stock | 478.7k | $0.00 | $0 | By Lundbeckfond Invest A/S | 03/16/2020 |
| 03/16/2020 | Enliven Therapeutics, Inc. | IMRA | Purchase | Common Stock | 187.5k | $16.00 | $3M | By Lundbeckfond Invest A/S | 03/16/2020 |
| 03/16/2020 | Enliven Therapeutics, Inc. | IMRA | Conversion | Common Stock | 1.2M | $0.00 | $0 | By Lundbeckfond Invest A/S | 03/16/2020 |
| 06/18/2019 | scPharmaceuticals Inc. | SCPH | Grant | Stock Option (Right to Buy) | 6.1k | $3.37 | $20.6k | | 06/18/2019 |
| 05/09/2019 | Trevi Therapeutics, Inc. | TRVI | Conversion | Common Stock | 776.5k | $0.00 | $0 | See Footnote | 05/09/2019 |
| 05/09/2019 | Trevi Therapeutics, Inc. | TRVI | Purchase | Common Stock | 375k | $10.00 | $3.8M | See Footnote | 05/09/2019 |
| 05/09/2019 | Trevi Therapeutics, Inc. | TRVI | Conversion | Series C Preferred Stock | 6.8M | $0.00 | $0 | See Footnote | 05/09/2019 |
| 05/07/2019 | Trevi Therapeutics, Inc. | TRVI | Grant | Stock Option (right to buy) | 23.7k | $10.00 | $236.8k | | 05/07/2019 |
| 06/19/2018 | scPharmaceuticals Inc. | SCPH | Grant | Stock Option (Right to Buy) | 6.1k | $5.53 | $33.9k | | 06/19/2018 |
| 11/21/2017 | scPharmaceuticals Inc. | SCPH | Purchase | Common Stock | 654.8k | $14.00 | $9.2M | By: Lundbeckfond Invest A/S | 11/21/2017 |
| 11/21/2017 | scPharmaceuticals Inc. | SCPH | Conversion | Series B Preferred Stock | 7.1M | $0.00 | $0 | By: Lundbeckfond Invest A/S | 11/21/2017 |
| 11/21/2017 | scPharmaceuticals Inc. | SCPH | Conversion | Series A Preferred Stock | 11.1M | $0.00 | $0 | By: Lundbeckfond Invest A/S | 11/21/2017 |
| 11/21/2017 | scPharmaceuticals Inc. | SCPH | Conversion | Common Stock | 984.4k | $0.00 | $0 | By: Lundbeckfond Invest A/S | 11/21/2017 |
| 11/21/2017 | scPharmaceuticals Inc. | SCPH | Conversion | Common Stock | 1.5M | $0.00 | $0 | By: Lundbeckfond Invest A/S | 11/21/2017 |